Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

BACKGROUND: In the present study, the prognostic impact of minimal residual disease during treatment on time to progression and overall survival was analyzed prospectively in patients with mantle cell lymphoma treated on the Cancer and Leukemia Group B 59909 clinical trial. DESIGN AND METHODS: Perip...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Liu, Hongtao, Johnson, Jeffrey L., Koval, Greg, Malnassy, Greg, Sher, Dorie, Damon, Lloyd E., Hsi, Eric D., Bucci, Donna Marie, Linker, Charles A., Cheson, Bruce D., Stock, Wendy
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2012
Assuntos:
Original Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3347669/
https://ncbi.nlm.nih.gov/pubmed/22102709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.050203
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares